跳至主要内容
临床试验/JPRN-UMIN000015081
JPRN-UMIN000015081招募中2 期

Pilot study of topical medicine of rapamycin for large diffuse plexiform neurofibroma of neurofibromatosis type 1 - Pilot study of topical medicine of rapamycin for large diffuse plexiform neurofibroma of neurofibromatosis type 1

Department of Dermatology Graduate School of Medicine, Osaka University0 个研究点目标入组 3 人开始时间: 2014年9月7日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
3

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who cannot carry out this treatment plan. 2) Patients who have allergy to macrolide antibiotics. 3) Patients who received oral or topical administration of rapamycin or RAD001 within six months prior to the study entry. 4) Patients who received topical treatment of tacrolimus within three months prior to the study entry. 5) Patients who received surgical therapy within six months prior to the study entry. 6) Patients who received radiotherapy or Neutron Capture Therapy within six months prior to the study entry. 7) Patients during pregnancy or lactation 8) Patients who were judged unsuitable for this study by the investigator.

研究者

发起方
Department of Dermatology Graduate School of Medicine, Osaka University

相似试验